Serum prostate-specific antigen levels (PSA) in men without clinical evidence of prostate cancer: age-specific reference ranges for total PSA, free PSA, and percent free PSA - what's new in 1997

By Kalish L.A.   McKinlay J.B.  

Urology, Vol. 54, Iss. 6, 1999-12 ,pp. : 1022-1027

Elsevier

Access to resources Recommend Favorite

The funding for this work came in part from NIH Grant DK47656-05 and the Richard M. Lucas Foundation.Serum percent free prostate-specific antigen in metastatic prostate cancer - influence of total PSA, prostate volume, and age

By Lin D.W.   Noteboom J.L.   Blumenstein B.A.   Ellis W.J.   Lange P.H.   Vessella R.L.  

Urology, Vol. 52, Iss. 3, 1998-09 ,pp. : 366-371

Elsevier

Access to resources Recommend Favorite

Percent free prostate-specific antigen after radiotherapy for prostate cancer - 8 to 10 ng/mL total PSA

By Crook J.M.   Bunting P.S.  

Urology, Vol. 52, Iss. 1, 1998-07 ,pp. : 100-105

Elsevier

Access to resources Recommend Favorite

Using proportions of free to total prostate-specific antigen, age, and total prostate-specific antigen to predict the probability of prostate cancer

By Chen Y.-T.   Luderer A.A.   Thiel R.P.   Carlson G.   Cuny C.L.   Soriano T.F.  

Urology, Vol. 47, Iss. 4, 1996-04 ,pp. : 518-524

Elsevier

Access to resources Recommend Favorite

Prostate-specific Antigen (PSA), PSA Density and Age-adjusted PSA Reference Values in Screening for Prostate Cancer: A Study of a Randomly Selected Population of 2,400 Men

By Gustafsson Ove   Mansour Essam   Norming Ulf   Carlsson Adelaida   Törnblom Magnus   Nyman Claes R.  

Scandinavian Journal of Urology and Nephrology, Vol. 32, Iss. 6, 1998-12 ,pp. : 373-377

Informa Healthcare

Access to resources Recommend Favorite